S. Taylor

发表

Head and neck cancer.

S. Taylor, 1991, Cancer chemotherapy and biological response modifiers.

Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer.

S. Taylor, C. Kittle, W. Warren, 1989, The Annals of thoracic surgery.

Phase I clinical trial of a single-dose and two weekly schedules of ICRF-159 (NSC-129943).

H. Hansen, S. Taylor, O. Selawry, 1974, Cancer chemotherapy reports.

Stage-IIB osteosarcomas around the knee. A study of MMP-9 in surviving tumour cells.

R. Grimer, S. Taylor, D. Mangham, 2002, The Journal of bone and joint surgery. British volume.

Cortical steroids in treatment of cancer; observations on effects of pituitary adrenocorticotropic hormone (ACTH) and cortisone in far advanced cases.

R. Morris, S. Taylor, J. Ayer, 1950, Journal of the American Medical Association.

Combined modality treatment using BID radiation for locally advanced non‐small cell lung carcinoma

S. Taylor, W. Warren, P. Bonomi, 1994, Cancer.

A randomized trial of adjuvant chemotherapy in head and neck cancer.

M. Norusis, D. Caldarelli, J. Hutchinson, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The incorporation of formate-C14 into human breast cancer in vitro.

S. Taylor, R. Winzler, H. Sky-Peck, 1960, Cancer research.

Combination chemotherapy for metastatic breast carcinoma. Prospective comparison of multiple drug therapy with L‐phenylalanine mustard

S. Pocock, P. Band, S. Taylor, 1976, Cancer.

Pre-treatment prognostic factors in stage III non-small cell lung cancer patients receiving combined modality treatment.

K. Rowland, S. Purl, S. Taylor, 1991, International journal of radiation oncology, biology, physics.

Combined modality therapy for locally advanced non‐small cell lung carcinoma

K. Rowland, S. Taylor, C. Kittle, 1990, Cancer.

Preoperative combined modality therapy for stage III M0 non-small cell lung carcinoma.

K. Rowland, S. Taylor, C. Kittle, 1987, International journal of radiation oncology, biology, physics.

Adjuvant chemoimmunotherapy of head and neck cancer.

S. Taylor, G. Sisson, D. Bytell, 1978, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Toxic reactions of 4‐amino‐pteroylglutamic acid (aminopterin) in patients with far‐advanced neoplastic disease

D. Slaughter, S. Taylor, G. Hass, 1950, Cancer.

Integration of surgery in multimodality therapy for esophageal cancer.

S. Taylor, D. Recine, W. Hartsell, 1997, American journal of clinical oncology.

Treatment of cerebral metastases from breast carcinoma with prednisolone.

S. Taylor, S. Kofman, J. Garvin, 1957, Journal of the American Medical Association.

Combined simultaneous cisplatin/fluorouracil chemotherapy and split course radiation in head and neck cancer.

K. Kiel, D. Caldarelli, J. Hutchinson, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Postoperative chemotherapy and chemohormonal therapy in women with node-positive breast cancer.

R. Gray, M. Knuiman, D. Tormey, 1986, NCI monographs : a publication of the National Cancer Institute.

Mitomycin and tamoxifen versus mitolactol, doxorubicin, and tamoxifen in patients with previously treated breast cancer.

R. Gelman, D. Tormey, S. Taylor, 1985, Cancer treatment reports.

Mutation of p53 in Squamous Cell Cancer of the Head and Neck: Relationship to Tumor Cell Proliferation

S. Leurgans, S. Leurgans, W. Panje, 1997, The Laryngoscope.

Phase II trials with procarbazine (NSC-77213), streptozotocin (NSC-85998), 6-THIOGUANINE (NSC-752), and CCNU (NSC-79037) in patients with metastatic cancer of the large bowel.

J. Hanley, J. Bennett, J. Horton, 1975, Cancer chemotherapy reports.

Cisplatin and 5-FU infusion chemotherapy in advanced, recurrent cancer of the head and neck: an Eastern Cooperative Oncology Group Pilot Study.

K. Rowland, S. Taylor, R. Deconti, 1986, Cancer treatment reports.

Mithramycin therapy in disseminated germinal testicular cancer.

J. Wolter, S. Taylor, C. Perlia, 1968, JAMA.

EXPERIENCE WITH VINCRISTINE IN SOLID TUMORS.

S. Taylor, C. Perlia, N. Gubisch, 1963, Cancer chemotherapy reports.

The use of prednisolone in the treatment of disseminated breast carcinoma

S. Taylor, R. Buenger, S. Kofman, 1958, Cancer.

Simultaneous cisplatin fluorouracil infusion and radiation followed by surgical resection in regionally localized stage III, non-small cell lung cancer.

D. Mathisen, S. Taylor, C. Kittle, 1987, The Annals of thoracic surgery.

Combined modality therapy for stage III non-small cell lung carcinoma: results of treatment and patterns of failure.

S. Taylor, C. Kittle, P. Bonomi, 1992, International journal of radiation oncology, biology, physics.

Severe cardiotoxicity during 5-fluorouracil chemotherapy: a case and literature report.

C. Kuropkat, S. Taylor, J. Clark, 1999, American journal of clinical oncology.

A randomized trial of adjuvant BCG immunotherapy in head and neck cancer.

W. Raynor, S. Taylor, G. Sisson, 1983, Archives of otolaryngology.

Combined chemotherapy and radiation for unresectable head and neck cancer.

S. Taylor, 1990, Cancer treatment and research.

Why has so much chemotherapy done so little in head and neck cancer?

S. Taylor, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group.

R. Gray, A. Recht, B. Fowble, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of metastatic breast cancer with a split-course high-dose chemotherapy regimen and autologous bone marrow transplantation.

M. Cobleigh, J. Wolter, S. Taylor, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Integration of chemotherapy into the combined modality therapy of head and neck squamous cancer.

S. Taylor, 1987, International journal of radiation oncology, biology, physics.

Controversies in the multimodality management of head and neck cancer.

S. Taylor, C. Thomas, 1991, Hematology/oncology clinics of North America.

A randomized comparison of high-dose infusion methotrexate versus standard-dose weekly therapy in head and neck squamous cancer.

W. Hauck, S. Taylor, T. Lad, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Integration of chemotherapy into a combined modality treatment plan for head and neck cancer: a review.

J. Glick, S. Taylor, 1981, International journal of radiation oncology, biology, physics.

An evaluation of ovarian status as a prognostic factor in disseminated cancer of the breast

S. Taylor, S. Cutler, A. J. Asire, 1970, Cancer.

Concomitant therapy with infusion of cisplatin and 5-fluorouracil plus radiation in stage III non-small cell lung cancer.

D. Mathisen, S. Taylor, P. Bonomi, 1988, NCI monographs : a publication of the National Cancer Institute.

The effect of sex hormones on advanced carcinoma of the breast

D. Slaughter, W. Smejkal, S. Taylor, 1948 .

Chemotherapy for squamous cell carcinoma of the head and neck: a progress report.

J. Glick, S. Taylor, L. Zehngebot, 1980, American journal of otolaryngology.

Phase II trial of etoposide, cisplatin, continuous infusion 5-fluorouracil, and simultaneous split-course radiation therapy in stage III non-small-cell bronchogenic carcinoma.

K. Rowland, S. Taylor, W. Warren, 1986, Seminars in oncology.

Pilot Study for the Evaluation of Simultaneous Cisplatin/5‐Fluorouracil Infusion and Limited Radiation Therapy in Regionally Recurrent Head and Neck Cancer (EST P‐C385)

S. Taylor, W. Hartsell, R. Haselow, 1994, American journal of clinical oncology.

Six-year results of the Eastern Cooperative Oncology Group trial of observation versus CMFP versus CMFPT in postmenopausal patients with node-positive breast cancer.

L. Sleeper, M. Knuiman, P. Carbone, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adriamycin, vincristine, dibromodulcitol, and hexamethylmelamine in advanced previously treated breast cancer: an ECOG pilot study.

J. Wolter, S. Taylor, 1981, Medical and pediatric oncology.

Surgical complications in patients with head and neck cancer receiving chemotherapy.

D. Caldarelli, J. Hutchinson, S. Taylor, 1986, Archives of otolaryngology--head & neck surgery.

Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer.

E. Vokes, D. Caldarelli, J. Hutchinson, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Antigen specificity of squamous cancers of the head and neck based on tumor site using the slide leukocyte adherence inhibition assay

S. Taylor, P. C. Safford, 1982, Journal of surgical oncology.

Comparison of 5-azacytidine (NSC-102816) with CCNU (NSC-79037) in the treatment of patients with breast cancer and evaluation of the subsequent use of cyclophosphamide (NSC-26271).

J. Horton, S. Taylor, T. Cunningham, 1974, Cancer chemotherapy reports.

Clinical use of 6‐aminonicotinamide in patients with disseminated neoplastic disease

S. Taylor, C. Perlia, H. Sky-Peck, 1961, Cancer.

PALA in advanced breast cancer A phase II pilot study by the ECOG

S. Taylor, G. Falkson, T. E. Davis, 1982, American journal of clinical oncology.

Hormonal treatment of breast cancer.

S. Taylor, C. Perlia, 1963, The Medical clinics of North America.

The role of corticosteroids in the treatment of malignant lymphomas

S. Taylor, C. Perlia, R. Eisenstein, 1962, Cancer.

Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy.

R. Gray, B. Fowble, D. Tormey, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in women more than 65 years old with advanced breast cancer: the elimination of age trends in toxicity by using doses based on creatinine clearance.

R. Gelman, S. Taylor, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node-positive breast cancer: a 10-year follow-up study of 728 Eastern Cooperative Oncology Group patients.

R. Gray, B. Fowble, D. Tormey, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II evaluation of Taxol in advanced head and neck cancer: an Eastern Cooperative Oncology group trial.

D. Neuberg, S. Taylor, G. Adams, 1993, Journal of the National Cancer Institute. Monographs.

Continued malignant cell proliferation in head and neck tumors during cytotoxic therapy.

W. Panje, D. Caldarelli, J. Hutchinson, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Concomitant cisplatin/5‐FU infusion and radiotherapy in advanced head and neck cancer: 8‐year analysis of results

K. Kiel, D. Caldarelli, J. Hutchinson, 1997, Head & neck.

Methotrexate compared with placebo in lung cancer

J. Edmonson, E. Kazam, J. Scotto, 1977, Cancer.

Regrowth resistance as a likely significant contributor to treatment failure in drug-sensitive neoplastic diseases.

A. Raza, H. Preisler, S. Taylor, 1997, Cancer investigation.

Hormonal modification in the treatment of disseminated cancer of the breast.

S. Taylor, 1956, The American journal of medicine.

The use of strontium-85 in the evaluation of bone metastases. A preliminary report.

S. Taylor, R. D. Ray, Y. Thibaudeau, 1963, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Adjuvant methotrexate and leucovorin in head and neck squamous cancer. Two-year follow-up of a pilot project.

E. Applebaum, W. Dewys, S. Taylor, 1978, Archives of otolaryngology.

Treatment of advanced head and neck cancer with concomitant radiation and chemotherapy.

D. Caldarelli, J. Hutchinson, S. Taylor, 1987, International journal of radiation oncology, biology, physics.

Combination chemotherapy pilot studies in head and neck squamous cell cancer.

W. Dewys, S. Taylor, J. M. Merrill, 1979, Cancer treatment reports.

Hormones in breast metastasis therapy.

R. Morris, S. Taylor, 1951, The Medical clinics of North America.

The effect of testosterone propionate on metastases to bone from carcinoma of the breast.

S. Taylor, F. Preston, J. L. Crumrine, 1949, The Journal of clinical endocrinology and metabolism.

Critical analysis of palliation produced by adrenalectomy in metastatic cancer of the female breast.

S. Taylor, C. Perlia, S. Kofman, 1956, Annals of internal medicine.

PANEL DISCUSSION ON THE PALLIATION OF ADVANCED CANCER IN THE OLDER AGE GROUPS †

D. Slaughter, S. Taylor, E. Bricker, 1957, Journal of the American Geriatrics Society.

Chemotherapy of cancer.

D. Slaughter, S. Taylor, 1950, The Illinois medical journal.

Improved control in advanced head and neck cancer with simultaneous radiation and cisplatin/5-FU chemotherapy.

K. Kiel, D. Caldarelli, J. Hutchinson, 1985, Cancer treatment reports.

Clinical study with bleomycin

J. Wolter, S. Taylor, C. Perlia, 1971, Cancer.

A correlation between the incorporation of formate‐C14 in tumors and the clinical course of patients with disseminated breast cancer

S. Taylor, S. Economou, Richard J. Winzler, 1960, Cancer.

Effect of ACTH and cortisone on advanced malignant disease.

S. Taylor, J. Ayer, L. Baskett, 1950, The Journal of laboratory and clinical medicine.

THE EFFECT OF HEATING WITH ALKALI ON THE CALORIGENIC ACTIVITY OF DESICCATED THYROID AND OF THYROXINE.

S. Taylor, W. O. Thompson, P. K. Thompson, 1937, The Journal of clinical investigation.

Cancer and the internist.

S. Taylor, 1966, Annals of internal medicine.

Retrospective analysis of hyperthermia for use in the palliative treatment of cancer: a multi-modality evaluation.

S. Taylor, L. Lanzl, F. Hendrickson, 1990, International journal of radiation oncology, biology, physics.

Tumor angiogenesis and p53 mutations: prognosis in head and neck cancer.

S. Leurgans, W. Panje, D. Caldarelli, 1998, Archives of otolaryngology--head & neck surgery.

Modulation of immunity in cancer patients by prostaglandin antagonists.

J. Harris, S. Taylor, D. Braun, 1989, Progress in clinical and biological research.

Streptozotocin therapy for metastatic insulinoma.

S. Taylor, T. B. Schwartz, W. Ryan, 1970, Archives of internal medicine.

Preoperative radiation therapy in regionally localized stage III non-small cell lung carcinoma: long-term results and patterns of failure.

S. Taylor, P. Bonomi, L. Faber, 1990, International journal of radiation oncology, biology, physics.

In vivo labelling with halogenated pyrimidines of squamous cell carcinomas and adjacent non‐involved mucosa of head and neck region

W. Panje, D. Caldarelli, J. Hutchinson, 1995, Cell proliferation.

Phase II trial of therapy with etoposide, 5-fluorouracil by continuous infusion, cisplatin, and simultaneous split-course radiation in stage III non-small cell bronchogenic carcinoma.

K. Rowland, S. Taylor, C. Kittle, 1988, NCI monographs : a publication of the National Cancer Institute.

Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study.

L. Kalish, J. Bennett, P. Carbone, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Experience of the Eastern Cooperative Oncology Group with doxorubicin as a single agent in patients with previously untreated breast cancer.

R. Gelber, S. Taylor, 1982, Cancer treatment reports.

Bleomycin in combination chemotherapy of metastatic Wilms tumor: a late recurrent case, refractory to conventional therapy.

W. Dewys, S. Taylor, J. M. Merrill, 1979, Medical and pediatric oncology.

Biochemical effects of mithramycin on cultured cells.

S. Taylor, G. Northrop, R. Northrop, 1969, Cancer research.

Lymphocyte responsiveness to thymosin in angioimmunoblastic lymphadenopathy with lymphomatous transformation.

S. Taylor, Samuel G. Taylor, 1982, Medical and pediatric oncology.

Combination chemotherapy compared to tamoxifen as initial therapy for stage IV breast cancer in elderly women.

R. Gelman, S. Taylor, G. Falkson, 1986, Annals of internal medicine.

Postmenopausal node-positive comparison of observation with CMFP and CMPF + tamoxifen adjuvant therapy: an Eastern Cooperative Oncology Group trial.

R. Gray, D. Tormey, S. Taylor, 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

THE TREATMENT OF ADDISON'S DISEASE WITH ADRENAL CORTEX EXTRACT1

S. Taylor, P. K. Thompson, W. Hoffman, 1939 .

A randomized comparison of two dosage schedules of methyl CCNU: Three‐week versus six‐week treatments

J. Wolter, W. Dewys, S. Taylor, 1979, Cancer.

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer.

W. Curran, R. Livingston, W. Sause, 1995, Journal of the National Cancer Institute.

Clinical studies of 5-fluorouracil + premarin in the treatment of breast cancer.

S. Pocock, S. Taylor, B. Shnider, 1975, Medical and pediatric oncology.

Effect of antifolic acid derivatives on patients with far-advanced carcinomatosis.

D. Slaughter, S. Taylor, 1948, The Journal of laboratory and clinical medicine.